Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Achieving the best of both worlds.

Ko AH, Cella D.

J Clin Oncol. 2013 Jan 1;31(1):3-4. doi: 10.1200/JCO.2012.46.4891. Epub 2012 Dec 3. No abstract available.

PMID:
23213099
2.

Second-line therapy in gemcitabine-pretreated patients with advanced pancreatic cancer.

Boeck S, Heinemann V.

J Clin Oncol. 2008 Mar 1;26(7):1178-9; author reply 1179. doi: 10.1200/JCO.2007.15.3304. No abstract available.

PMID:
18309957
3.

Evolving panorama of treatment for metastatic pancreas adenocarcinoma.

O'Reilly EM.

J Clin Oncol. 2013 May 1;31(13):1621-3. doi: 10.1200/JCO.2013.48.7660. Epub 2013 Apr 1. No abstract available.

PMID:
23547071
4.

Will gemcitabine monotherapy be dethroned as the adjuvant chemotherapy in pancreatic adenocarcinoma?

Kourie HR, Gharios J, Kattan J.

Future Oncol. 2017 Feb;13(3):197-199. doi: 10.2217/fon-2016-0316. Epub 2016 Sep 14. No abstract available.

5.

Clinical update of gemcitabine in pancreas cancer.

Au E.

Gan To Kagaku Ryoho. 2000 May;27 Suppl 2:469-73. Review.

PMID:
10895197
6.

[Chemoradiation for pancreatic adenocarcinoma].

Flandin I, Mornex F, Claude L, Kubas A, Khodri M, Wautot V, Mazeron R, Partensky C.

Cancer Radiother. 2004 Nov;8 Suppl 1:S80-7. Review. French.

PMID:
15679252
7.

[Nab-paclitaxel use in pancreatic cancer: practical aspects and consequences in a French oncology day-care unit].

Hubault M, Faure R, Walter T, Forestier J, Lombard-Bohas C, Pivot C.

Bull Cancer. 2015 May;102(5):403-4. doi: 10.1016/j.bulcan.2015.03.004. Epub 2015 Apr 9. French. No abstract available.

PMID:
25866372
8.

[Gemzar (gemcitabine)--a new chemotherapeutic agent for pancreatic cancer].

Merimsky O, Chaitchik S.

Harefuah. 1997 Sep;133(5-6):208-12. Review. Hebrew. No abstract available.

PMID:
9461693
9.

[Gemcitabine chemotherapy for patients with advanced or relapsed pancreatic cancer].

Ohkawa S.

Nihon Rinsho. 2006 Jan;64 Suppl 1:198-202. Review. Japanese. No abstract available.

PMID:
16457249
10.

[How I treat ... An advanced pancreatic cancer].

Polus M, Jerusalem G, Sautois B, Silvestre RM, Fillet G.

Rev Med Liege. 2002 Mar;57(3):131-4. Review. French.

PMID:
12014258
11.

Treatment of metastatic pancreatic cancer.

Ko AH, Tempero MA.

J Natl Compr Canc Netw. 2005 Sep;3(5):627-36. Review.

PMID:
16194454
12.

Locally advanced pancreatic cancer: where should we go from here?

Philip PA.

J Clin Oncol. 2011 Nov 1;29(31):4066-8. doi: 10.1200/JCO.2011.37.2532. Epub 2011 Oct 3. No abstract available.

PMID:
21969514
13.

[Gemcitabine treatment of pancreatic cancer peritonitis].

Horiki N, Maruyama M, Fujita Y, Suzuki Y, Tanaka T, Shimomura M, Tanigawa K, Sasaki H, Fujiwara M, Suzuki K, Imoto I, Adachi Y.

Nihon Shokakibyo Gakkai Zasshi. 2003 Jan;100(1):73-8. Review. Japanese. No abstract available.

PMID:
12601933
14.

Gemcitabine combined with infusional 5-fluorouracil and high-dose leucovorin for the treatment of advanced carcinoma of the pancreas.

Oztop I, Yilmaz U, Yavuzsen T, Yaren A, Tarhan O, Sagol O, Coker A, Alakavuklar M.

Chemotherapy. 2004 Jun;50(3):127-32.

PMID:
15282439
15.

Gemcitabine: a ray of hope for pancreatic cancer?

Gupta P.

Natl Med J India. 1997 Mar-Apr;10(2):72-3. No abstract available.

PMID:
9153984
16.

Combined gemcitabine and alpha-interferon therapy for pancreatic cancer: report of a case.

Sawai H, Okada Y, Tanaka M, Funahashi H, Yamamoto M, Takeyama H, Manabe T.

Dig Dis Sci. 2006 Jul;51(7):1285-9. No abstract available.

PMID:
16944027
17.

Capecitabine in carcinoma of the pancreas.

Smith DB, Neoptolemos JP.

Expert Opin Pharmacother. 2006 Aug;7(12):1633-9. Review.

PMID:
16872266
18.

Pancreatic cancer.

[No authors listed]

Clin Evid. 2003 Jun;(9):528-33. Review. No abstract available. Update in: Clin Evid. 2004 Jun;(11):626-32.

PMID:
12967377
19.

Gemcitabine doublets in advanced pancreatic cancer: should we move on?

Rocha Lima CM, Flores AM.

J Clin Oncol. 2006 Jan 20;24(3):327-9. Epub 2005 Dec 12. No abstract available.

PMID:
16344312
20.

Unprecedented case of tumor lysis syndrome in a patient with metastatic pancreatic adenocarcinoma.

Ling W, Sachdeva P, Wong AS, Lee SC, Zee YK.

Pancreas. 2012 May;41(4):659-61. doi: 10.1097/MPA.0b013e3182327a16. No abstract available.

PMID:
22504387

Supplemental Content

Support Center